2020 marks the 30 year anniversary of specialist fire protection company, DoseTech. 

Founded as a chemical dosing tech-nology company for industry, DoseTech changed its focus about 20 years ago to concentrate on foam dosing for the special risk fire protection industry. 

In partnership with FireDos of Germany, DoseTech has successfully introduced advanced methods of accurate foam addition to firefighting applications.  The benefits of DoseTech solutions include reduced foam wastage, easy installation, testing and maintenance, as well as lowered operational costs.

DoseTech’s most notable projects include harbour fuel out-loading protection installation and refinery firefighting fixed and mobile foam applications, including the first exclusive foam trailer for refinery use in South Africa. 

The company’s building-top helipad special risk fire protection project has received recognition as a new industry standard. 

DoseTech partnerships extend to a number of internationally-recognised manufacturers, such as AKRON Brass and Mueller from the US and Delta Fire UK. Products include monitors for various  applications, from manually operated to fully automated and remote-controlled units, end-of-line nozzles, water valves, hydrants, foam, bund pourers, tank top pourers and rim pourers. 

In addition, AKRON manufactures a range of severe duty monitors for raw water applications such as hydro mining dump recovery and heavy vehicle washing. 

DoseTech offers specialist advice on the selection and installation of its product ranges, as well as pre-commissioning and commissioning services, full maintenance contracts and customer training. 

DoseTech is a level 2 broad-based black economic empowerment company and prides itself on providing innovation and the latest technology to the South African market. 

“Our German partner FireDos GmbH have launched Gen lll of their foam dosing FireDos units and will be exhibiting at the Interschutz expo in June 2020 and we look forward to meeting many of our SA customers at their stand” says DoseTech MD Mike Feldon.